COMMUNIQUÉS West-GlobeNewswire

-
Pennant Group to Participate in the 2024 RBC Global Healthcare Conference
13/05/2024 -
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
13/05/2024 -
Blue Cross and Blue Shield of Minnesota Collaborate with Black Market Reads Podcast to Highlight Racial and Health Inequities Impacting Black Communities
13/05/2024 -
Transactions in Connection with Share Buy-back Program
13/05/2024 -
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
13/05/2024 -
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
13/05/2024 -
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
13/05/2024 -
Sanara MedTech Inc. Announces First Quarter 2024 Results
13/05/2024 -
Stride Autism Centers Opens New Facility in Sioux Falls to Extend Autism Support in South Dakota
13/05/2024 -
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
13/05/2024 -
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
13/05/2024 -
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
13/05/2024 -
QHSLab, Inc. Announces Strong First Quarter 2024 Results with Significant Reduction in Operating Expenses and Positive Net Operating Income
13/05/2024 -
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
13/05/2024 -
Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock
13/05/2024 -
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
13/05/2024 -
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
13/05/2024 -
Safety Shot Partners with Gopuff
13/05/2024 -
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024
Pages